Search
Search Funnelback University
- Refined by:
- Date: Past month
Did you mean economiespast |u:www.enterprise.cam.ac.uk?
Your query has been expanded to Economics test |u:www.enterprize.cam.ac.uk. Search for Economics test |u:www.enterprise.cam.ac.uk instead.
1 -
10 of
36
search results for Economics test |u:www.enterprise.cam.ac.uk or Economics test |u:www.enterprize.cam.ac.uk
where 2
match all words and 34
match some words.
Fully-matching results
-
Spin-out PredictImmune wins £4.3m from Wellcome to evaluate its…
https://www.enterprise.cam.ac.uk/news/spin-predictimmune-wins-4-3m-wellcome-evaluate-prognostic-test/22 Feb 2023: Spin-out PredictImmune wins £4.3m from Wellcome to evaluate its prognostic test. ... Published studies indicate that there are likely to be significant clinical and economic benefits in the use of biomarker tests to guide first line treatment based on -
Cambridge Enterprise invests in PredictImmune – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-invests-in-predictimmune/22 Feb 2023: PredictImmune has carried out considerable market research into the medical need for the tests and the health economic benefits that they will deliver. ... Tags:Image: Test tubes. Stay in touch with the latest updates from Cambridge Enterprise. Results that match 1 of 2 words
-
Versed AI wins the 2019 Postdoc Business Plan Competition – Cambridge …
https://www.enterprise.cam.ac.uk/news/versed-ai-wins-the-2019-postdoc-business-plan-competition/23 Feb 2023: genetic test that benefits cancer patients by pinpointing the best drug for treating their tumour; and Inkling, which is developing graphene-enhanced windblade coatings that are resistant to rain erosion, thereby -
University of Cambridge breaks its early stage investment record for…
https://www.enterprise.cam.ac.uk/news/university-of-cambridge-breaks-its-early-stage-investment-record-for-third-consecutive-year/22 Feb 2023: This was the fourth year of operation for the Enterprise Fund, which was announced as part of the SEIS programme in the government’s 2012 budget, established to stimulate economic growth. -
University of Cambridge breaks its early stage investment record for…
https://www.enterprise.cam.ac.uk/news/university-of-cambridge-breaks-its-early-stage-investment-record-for-the-fourth-consecutive-year/22 Feb 2023: This was the fourth year of operation for the Enterprise Fund, which was announced as part of the SEIS programme in the government’s 2012 budget, established to stimulate economic growth. -
The role of stem cells in developing new drugs – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/the-role-of-stem-cells-in-developing-new-drugs/22 Feb 2023: Consequently, it is often affected by toxic compounds. Demonstrating that a new drug candidate is free from liver toxicity is a key test in the development process, and it is a ... test that most drug candidates fail. -
The economic impact of the University of Cambridge – Cambridge…
https://www.enterprise.cam.ac.uk/news/the-economic-impact-of-the-university-of-cambridge/21 Mar 2023: London Economics, one of Europe’s leading specialist economics and policy consultancies, was commissioned to assess the University’s economic impact through a range of activities. ... This report by London Economics is a comprehensive attempt to -
Storm Therapeutics announces appointment of CEO and Chairman –…
https://www.enterprise.cam.ac.uk/news/storm-therapeutics-appoints-ceo-and-chairman/23 Feb 2023: patients”. Tags:Image: Test tubes. Stay in touch with the latest updates from Cambridge Enterprise. -
Spin-out Riverlane, a quantum computing software developer, raises…
https://www.enterprise.cam.ac.uk/news/spin-out-riverlane-a-quantum-computing-software-developer-secures-3-25m/23 Feb 2023: Riverlane is building a simulation engine for microscopic systems to replace expensive laboratory tests with computer simulation. -
Spin-out PredictImmune announces new patent grants and allowances in…
https://www.enterprise.cam.ac.uk/news/spin-predictimmune-announces-new-patent-grants-allowances-uk-eu-canada/22 Feb 2023: The UK, EU and Canadian patents expand PredictImmune’s existing patent portfolio and further protect the organisation’s current IP in the development of prognostic tests across a broad range of ... The R&D phase of the test has been completed and the
Refine your results
clear all
Date
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.